It's another week of debate over PBS deferrals. Unfortunately, there appears to be an effort to limit public discussion. Given the obvious risk to patients and the implications for the access agenda, which is flailing against the backdrop of deferrals, how does that make sense? It also stands in stark contrast to when cost recovery was introduced. …
Latest Video
New Stories
-
The 'Dispatched' Week in Review - 12 September
September 12, 2025 - - Podcast -
Surely this is what the collapse of moral authority must look like
September 11, 2025 - - Latest News -
Artificial Intelligence can only accelerate Health Technology Assessments
September 11, 2025 - - Latest News -
Australian biotechs shine at Asia Pacific Cell and Gene Therapy Awards
September 11, 2025 - - Australian Biotech -
Trump administration announces new disclosure rules for medicine advertising
September 10, 2025 - - Latest News -
Chemist Warehouse partners with DoorDash to deliver health and beauty on demand
September 10, 2025 - - Latest News -
Cancer leaders unite to tackle equity and innovation at 2025 PCPA Summit
September 10, 2025 - - Latest News